中国P站

Molecular mechanisms; Viral pathogenesis; Immune evasion; Host-pathogen interaction; SARS-CoV-2; Zika Virus; Ebola Virus; Influenza A Virus; Dengue Virus; Neuropathogenesis

Introduction

The article updates understanding of SARS-CoV-2 molecular mechanisms driving pathogenesis, covering viral entry via ACE2 and TMPRSS2, replication dynamics, and host immune responses. It details molecular alterations observed in various organs, emphasizing lung pathology, endothelial dysfunction, and the immunological underpinnings of severe COVID-19. Key insights involve how the virus manipulates cellular pathways to ensure infectivity and systemic disease manifestations [1].

This review explores molecular mechanisms by which Zika virus (ZIKV) orchestrates neuropathogenesis, focusing on congenital Zika syndrome. It outlines how ZIKV targets neural progenitor cells, disrupts neurogenesis, and triggers apoptosis, contributing to microcephaly and other neurological defects. The article elucidates specific viral components and host factors involved in these critical pathogenic pathways [2].

This study examines Ebola virus (EBOV) molecular strategies to evade host immune surveillance and establish infection. It highlights critical roles of viral proteins like VP35 and VP24 in antagonizing interferon signaling and modulating host defense mechanisms. Understanding these molecular interactions is essential for developing effective antiviral therapies and preventive measures [3].

This comprehensive review dissects influenza A virus (IAV) molecular pathogenesis, detailing entry, replication, assembly, and release. It underscores interplay between viral factors and host immune responses, explaining how specific viral proteins manipulate cellular pathways to promote infection and cause severe disease, considering host genetics in susceptibility [4].

This review concentrates on Chikungunya virus (CHIKV) pathogenesis, specifically its molecular mechanisms contributing to persistent arthralgia. It covers viral replication, interactions with host cells, and resultant inflammatory responses in affected joints. Authors explore how various viral proteins and host factors drive disease progression, pinpointing potential targets for novel antiviral therapeutic strategies [5].

This article illuminates Dengue virus (DENV) molecular pathogenesis, including its replication cycle and complex host cell interactions. It scrutinizes how DENV manipulates host immune responses, focusing on non-structural proteins in viral evasion and molecular mechanisms leading to severe forms of dengue fever, such as plasma leakage and hemorrhage [6].

This review offers an overview of Nipah virus (NiV), detailing its molecular structure, replication cycle, and pathogenesis. It highlights how NiV causes severe encephalitis and respiratory illness by targeting specific host cells and modulating immune responses. The article also discusses current molecular diagnostic tools and emerging therapeutic strategies against this highly virulent pathogen [7].

This review elucidates Crimean-Congo Hemorrhagic Fever virus (CCHFV) molecular pathogenesis. It covers viral replication, host factor interaction, and the severe inflammatory response triggering hemorrhagic manifestations. The article discusses how specific viral proteins interfere with host antiviral pathways and contribute to organ damage and coagulopathy, driving disease severity [8].

This article provides an update on MERS-CoV molecular pathogenesis, detailing its entry mechanisms via DPP4 receptors, sophisticated replication strategies, and host immune responses. It elaborates on how MERS-CoV viral proteins manipulate host cellular processes to evade antiviral defenses, ultimately leading to severe acute respiratory syndrome and systemic complications [9].

This review focuses on Rift Valley Fever virus (RVFV) molecular pathogenesis, detailing its replication cycle, intricate host cell interactions, and resulting severe disease in humans and animals. It explains how viral proteins interfere with host innate immunity, leading to widespread inflammation, severe liver damage, and hemorrhagic fever, highlighting potential molecular targets for intervention [10].

Description

The understanding of molecular mechanisms driving SARS-CoV-2 pathogenesis covers viral entry via ACE2 and TMPRSS2, replication dynamics, and host immune responses. It details molecular alterations observed in various organs, emphasizing lung pathology, endothelial dysfunction, and the immunological underpinnings of severe COVID-19. Key insights involve how the virus manipulates cellular pathways to ensure infectivity and systemic disease manifestations [1]. Similarly, MERS-CoV molecular pathogenesis involves specific entry mechanisms via DPP4 receptors, sophisticated replication strategies, and subsequent host immune responses. MERS-CoV viral proteins skillfully manipulate host cellular processes to evade antiviral defenses, ultimately leading to severe acute respiratory syndrome and various systemic complications [9]. A comprehensive review dissects influenza A virus (IAV) pathogenesis, detailing stages from viral entry and replication to assembly and release. It underscores the intricate interplay between viral factors and host immune responses, explaining how specific viral proteins manipulate cellular pathways to promote infection and cause severe disease, and considers the role of host genetics in susceptibility [4].

Zika virus (ZIKV) orchestrates neuropathogenesis, particularly focusing on congenital Zika syndrome. It outlines how ZIKV targets neural progenitor cells, disrupts neurogenesis, and triggers apoptosis, contributing to microcephaly and other neurological defects. The article elucidates specific viral components and host factors involved in these critical pathogenic pathways [2]. Furthermore, Nipah virus (NiV) causes severe encephalitis and respiratory illness by targeting specific host cells and modulating immune responses. An overview details its molecular structure, replication cycle, and mechanisms of pathogenesis, also discussing current molecular diagnostic tools and emerging therapeutic strategies against this highly virulent pathogen [7].

Ebola virus (EBOV) employs molecular strategies to evade host immune surveillance and establish infection. Viral proteins like VP35 and VP24 play critical roles in antagonizing interferon signaling and modulating host defense mechanisms, underscoring the importance of understanding these molecular interactions for developing effective antiviral therapies [3]. Dengue virus (DENV) pathogenesis involves its replication cycle and complex interactions with host cellular machinery. DENV manipulates host immune responses, with non-structural proteins playing a key role in viral evasion and leading to severe forms of dengue fever, such as plasma leakage and hemorrhage [6]. Crimean-Congo Hemorrhagic Fever virus (CCHFV) pathogenesis covers viral replication, interaction with crucial host factors, and the severe inflammatory response it triggers, leading to profound hemorrhagic manifestations. Specific viral proteins interfere with host antiviral pathways, contributing to widespread organ damage and coagulopathy, driving disease severity [8]. Rift Valley Fever virus (RVFV) pathogenesis details its replication cycle, intricate interactions with host cells, and resulting severe disease manifestations. Viral proteins specifically interfere with host innate immunity, leading to widespread inflammation, severe liver damage, and hemorrhagic fever, highlighting potential molecular targets for intervention [10].

Chikungunya virus (CHIKV) pathogenesis focuses on its molecular mechanisms contributing to persistent arthralgia. It covers viral replication, interactions with host cells, and the resultant inflammatory responses in affected joints. Exploration of various viral proteins and host factors driving disease progression helps pinpoint potential targets for novel antiviral therapeutic strategies [5]. Across these diverse viral infections, a consistent theme is the manipulation of host cellular processes and immune responses at the molecular level. These studies collectively highlight the critical importance of elucidating specific viral components and host factors in unraveling the intricacies of viral pathogenesis, thereby paving the way for advanced diagnostics and innovative therapeutic interventions.

Conclusion

This compilation surveys the intricate molecular mechanisms employed by various viruses to establish infection and cause disease. Across diverse pathogens like SARS-CoV-2, Zika Virus, Ebola Virus, Influenza A Virus, Chikungunya Virus, Dengue Virus, Nipah Virus, Crimean-Congo Hemorrhagic Fever Virus, MERS-CoV, and Rift Valley Fever Virus, a common thread emerges: the sophisticated manipulation of host cellular pathways. These viruses target specific receptors for entry, orchestrate complex replication dynamics, and deploy an array of viral proteins to antagonize host immune responses, particularly interferon signaling, thereby ensuring infectivity and systemic disease manifestations. The pathological outcomes described are notably varied, ranging from acute respiratory syndromes, severe encephalitis, and neuropathogenesis leading to microcephaly, to persistent arthralgia and life-threatening hemorrhagic fevers with associated widespread organ damage and coagulopathy. Key insights detail precisely how these pathogens disrupt neurogenesis, promote excessive inflammation, induce endothelial dysfunction, and adeptly manipulate host defense mechanisms at a molecular level. Furthermore, the articles shed light on the roles of specific viral components and host factors that drive disease progression. Understanding these precise molecular interactions and their implications for host response is vital for developing effective diagnostic tools, targeted antiviral therapies, and robust preventive strategies against these highly virulent pathogens. The collected reviews collectively emphasize the critical importance of elucidating viral molecular pathology in understanding disease progression and identifying promising intervention points.

References

1. Ka-Kin L, Wing TCY, Chun PWC (2022) .Pathology 54:809-819.

   , ,

2. Ana SPR, Mariana BL, Ana CCP (2021) .Front Mol Biosci 8:642057.

   , ,

3. Robert RJ, Daniel JJ, Adam SA (2020) .Viruses 12:78.

   , ,

4. Qianqian G, Jinling L, Jianhua H (2023) .J Med Virol 95:e28822.

   , ,

5. Pooja G, Varun G, Shalu C (2023) .Future Virol 18:351-366.

   , ,

6. Maria VC, Luana VCO, Livia FBS (2022) .Viruses 14:776.

   , ,

7. Jessica KL, Wenjie S, Joseph JT (2023) .Microorganisms 11:2006.

   , ,

8. Ebtisam ME, Sherif ME, Marwa FA (2023) .Front Microbiol 14:1259160.

   , ,

9. Mohammed KZ, Fahad AA, Mohammed AA (2022) .Microorganisms 10:1025.

   , ,

10. Shadi SZ, Mohamed AE, Mostafa AE (2023) .Viruses 15:1691.

    , ,